Science Explorer Back to mapMap

Most cited papers from DBV Technologies (France)

What are the most cited papers from DBV Technologies (France)?

The most cited paper from DBV Technologies (France) is "Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy" (David Mark Fleischer et al., 2019), with 279 citations. Next come "Cow's milk epicutaneous immunotherapy in children: A pilot trial of safety, acceptability, and impact on allergic reactivity" (272) and "Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity" (221).

Showing 50 of 60 papers. Every paper with more than 18 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy David Mark Fleischer et al. · JAMA Open access 22 Feb 2019 279
2 Cow's milk epicutaneous immunotherapy in children: A pilot trial of safety, acceptability, and impact on allergic reactivity Christophe M. Dupont, Nicolas Kalach, Pascale Soulaines et al. · Journal of Allergy and Clinical Immunology May 2010 272
3 Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity Hugh A. Sampson et al. · JAMA Open access 14 Nov 2017 221
4 COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee Paul Turner, Ignacio Javier Ansotegui, Dianne Elizabeth Campbell et al. · World Allergy Organization Journal Open access Feb 2021 172
5 Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy Lucie Mondoulet, Vincent Dioszeghy, Mélanie Ligouis et al. · Clinical & Experimental Allergy 11 Mar 2010 169
6 Use of combinations of in vitro quality assessments to predict fertility of bovine semen Eli Sellem, M. L. W. J. Broekhuijse, Lucie Chevrier et al. · Theriogenology 30 Jul 2015 167
7 Epicutaneous Immunotherapy Results in Rapid Allergen Uptake by Dendritic Cells through Intact Skin and Downregulates the Allergen-Specific Response in Sensitized Mice Vincent Dioszeghy, Lucie Mondoulet, Véronique Dhelft et al. · The Journal of Immunology 14 Apr 2011 162
8 Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis Leticia Tordesillas, Lucie Mondoulet, Ana-Belén Blázquez et al. · Journal of Allergy and Clinical Immunology Open access 14 Jun 2016 151
9 Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy Matthew Greenhawt et al. · New England Journal of Medicine Open access 10 May 2023 139
10 Epicutaneous Immunotherapy Using a New Epicutaneous Delivery System in Mice Sensitized to Peanuts Lucie Mondoulet, Vincent Dioszeghy, Jeroen AJ Vanoirbeek et al. · International Archives of Allergy and Immunology 20 Oct 2010 111
11 Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch Stacie M. Jones, Wence Agbotounou, David Mark Fleischer et al. · Journal of Allergy and Clinical Immunology Open access 25 Feb 2016 107
12 Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results David Mark Fleischer et al. · Journal of Allergy and Clinical Immunology Open access 10 Jul 2020 103
13 Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice Lucie Mondoulet, Vincent Dioszeghy, Emilie Puteaux et al. · Clinical and Translational Allergy Open access 2012 86
14 Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model Lucie Mondoulet, Vincent Dioszeghy, Emilie Puteaux et al. · Journal of Allergy and Clinical Immunology 9 Jan 2015 84
15 Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut Vincent Dioszeghy, Lucie Mondoulet, Emilie Puteaux et al. · Cellular and Molecular Immunology Open access 11 Apr 2016 81
16 Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice Lucie Mondoulet, Vincent Dioszeghy, Thibaut Larcher et al. · PLoS ONE Open access 21 Feb 2012 79
17 PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs Leticia Tordesillas, Daniel Lozano‐Ojalvo, David Dunkin et al. · Nature Communications Open access 3 Dec 2018 78
18 The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long‐term protection from eosinophilic disorders in peanut‐sensitized mice Vincent Dioszeghy, Lucie Mondoulet, Véronique Dhelft et al. · Clinical & Experimental Allergy Open access 25 Mar 2014 73
19 Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut‐sensitized mice Lucie Mondoulet, Vincent Dioszeghy, Florence Busato et al. · Allergy Open access 19 May 2018 72
20 Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee Paul Turner et al. · World Allergy Organization Journal Open access 10 Feb 2024 69
21 Using data from food challenges to inform management of consumers with food allergy: A systematic review with individual participant data meta-analysis Nandinee Patel, Daniel C. Adelman, Katherine Anagnostou et al. · Journal of Allergy and Clinical Immunology ReviewOpen access 9 Feb 2021 68
22 Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results Jacqueline A. Pongracic et al. · The Journal of Allergy and Clinical Immunology In Practice Open access 27 Nov 2021 62
23 Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors Chantal S. Colmont, Anne‐Catherine Raby, Vincent Dioszeghy et al. · Nephrology Dialysis Transplantation Open access Jun 2011 57
24 Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice Vincent Dioszeghy, Lucie Mondoulet, Léo Laoubi et al. · Frontiers in Immunology Open access 3 Sep 2018 54
25 Effect of semen dilution to low-sperm number per dose on motility and functionality of cryopreserved bovine spermatozoa using low-density lipoproteins (LDL) extender: Comparison to Triladyl® and Bioxcell® O. Vera-Munoz, L. Amirat-Briand, Thais Díaz et al. · Theriogenology 31 Dec 2008 50
26 Diffusion curves Alexandrina Orzan, Adrien Bousseau, Pascal Barla et al. · Communications of the ACM 18 Jun 2013 49
27 Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies Audrey DunnGalvin, David Mark Fleischer, Dianne Elizabeth Campbell et al. · The Journal of Allergy and Clinical Immunology In Practice Open access 22 Aug 2020 48
28 Effect of simulated gastro‐duodenal digestion on the allergenic reactivity of beta‐lactoglobulin Apostolos Bossios, Μαρία Θεοδωροπούλου, Lucie Mondoulet et al. · Clinical and Translational Allergy Open access 2011 47
29 NADP-MALIC ENZYME 1 Affects Germination after Seed Storage in Arabidopsis thaliana Farzaneh Yazdanpanah, Verónica Graciela Maurino, Tabea Mettler‐Altmann et al. · Plant and Cell Physiology Open access 31 Oct 2018 43
30 Effect of glutamine on post-thaw motility of bull spermatozoa after association with LDL (low density lipoproteins) extender: Preliminary results L. Amirat-Briand, D. Bencharif, O. Vera-Munoz et al. · Theriogenology 18 Mar 2009 43
31 Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis Paul Turner et al. · The Journal of Allergy and Clinical Immunology In Practice Open access 23 Aug 2021 39
32 Commercial claims costs related to health care resource use associated with a diagnosis of peanut allergy Marcus S Shaker, Joseph M. Chalil, Oth Tran et al. · Annals of Allergy Asthma & Immunology Open access 16 Jan 2020 36
33 RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine Pierre‐Louis Hervé, Charlotte Deloizy, Delphyne Descamps et al. · Nanomedicine Nanotechnology Biology and Medicine Open access 23 Aug 2016 32
34 Core Outcome Set for IgE ‐mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘ COMFA ’ Anastasia Demidova et al. · Allergy Open access 3 Mar 2024 30
35 GCNBoost: Artwork Classification by Label Propagation through a Knowledge Graph Cheikh Brahim El Vaigh, Noa García, Benjamin Renoust et al. Conference paper 24 Aug 2021 30
36 Managing Food Allergy in Schools During the COVID-19 Pandemic Matthew Greenhawt, Marcus S Shaker, David R. Stukus et al. · The Journal of Allergy and Clinical Immunology In Practice Open access 22 Jul 2020 30
37 Epicutaneous Immunotherapy for Food Allergy as a Novel Pathway for Oral Tolerance Induction Lucie Mondoulet, Vincent Dioszeghy, Claude Thébault et al. · Immunotherapy 19 Nov 2015 30
38 Effects of the Inclusion of Equex STM into Tris‐Based Extender on the Motility of Dog Spermatozoa Incubated at 5°C Wojciech Niżański, M. Klimowicz, Agnieszka Partyka et al. · Reproduction in Domestic Animals Jul 2009 30
39 In vivo fertility of bull semen following cryopreservation with an LDL (low density lipoprotein) extender: Preliminary results of artificial inseminations L. Amirat-Briand, D. Bencharif, O. Vera-Munoz et al. · Animal Reproduction Science 30 Sep 2010 30
40 Genetic and Epigenetic Variations of HPV52 in Cervical Precancer Katharine J. Bee, Ana Gradíssimo, Zigui Chen et al. · International Journal of Molecular Sciences Open access 16 Jun 2021 29
41 Epicutaneous Immunotherapy (EPIT) Is Effective and Safe to Treat Peanut Allergy: A Multi-National Double-Blind Placebo-Controlled Randomized Phase IIb Trial Hugh A. Sampson et al. · Journal of Allergy and Clinical Immunology Feb 2015 29
42 Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense) Lucie Mondoulet, Vincent Dioszeghy, Mélanie Ligouis et al. · ISRN Allergy Open access 2 Feb 2012 29
43 Estimated risk reduction to packaged food reactions by epicutaneous immunotherapy (EPIT) for peanut allergy Benjamin C. Remington, Tanja Krone, Edwin Kim et al. · Annals of Allergy Asthma & Immunology Open access 20 Aug 2019 28
44 DC-40 GHz SPDTs in 22 nm FD-SOI and Back-Gate Impact Study Martin Rack, Lucas Nyssens, Sidina Wane et al. Conference paperOpen access Aug 2020 27
45 Unmet needs of children with peanut allergy Edmond S. Chan, Chitra Dinakar, Erika Gonzales-Reyes et al. · Annals of Allergy Asthma & Immunology Open access 30 Jan 2020 25
46 Epicutaneous allergen immunotherapy induces a profound and selective modulation in skin dendritic-cell subsets Léo Laoubi, Morgane Lacoffrette, Séverine Valsesia et al. · Journal of Allergy and Clinical Immunology Open access 29 Jun 2022 24
47 Analytical capacitive sensor sensitivity distribution and applications J. W. Lucas, Stéphane Holé, Christophe Bâtis · Measurement Science and Technology 17 Aug 2006 23
48 Atopy Patch Test for Early Diagnosis of Cow's Milk Allergy in Preterm Infants Christophe M. Dupont, Pascale Soulaines, Alexandre Lapillonne et al. · Journal of Pediatric Gastroenterology and Nutrition 19 Mar 2010 23
49 The Impact of Allergy Specialty Care on Health Care Utilization Among Peanut Allergy Children in the United States Matthew Greenhawt, Elissa Michele Abrams, Joseph M. Chalil et al. · The Journal of Allergy and Clinical Immunology In Practice Open access 13 Aug 2022 22
50 Reproducibility of food challenge to cow’s milk: Systematic review with individual participant data meta-analysis Paul Turner, Nandinee Patel, Dianne Elizabeth Campbell et al. · Journal of Allergy and Clinical Immunology ReviewOpen access 7 Jun 2022 22

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.